Interventions Don't Improve Osteoarthritis Outcomes

Share this content:
Interventions Don't Improve Osteoarthritis Outcomes
Interventions Don't Improve Osteoarthritis Outcomes

TUESDAY, Jan. 17, 2017 (HealthDay News) -- Patient- and provider-based interventions do not improve osteoarthritis outcomes, according to a study published online Jan. 17 in the Annals of Internal Medicine.

Kelli D. Allen, Ph.D., from the University of North Carolina at Chapel Hill, and colleagues examined whether patient-based, provider-based, and patient-provider interventions could improve osteoarthritis outcomes. A total of 537 outpatients with symptomatic hip or knee osteoarthritis from 10 Duke University Health System community-based primary care clinics were randomized to patient, provider, or patient-provider interventions. The patient intervention focused on weight management, physical activity, and cognitive-behavioral pain management; the provider intervention included electronic delivery of patient-specific osteoarthritis treatment recommendations to providers.

The researchers found that, compared with usual care, there were no significant differences in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score changes from baseline to 12 months in the patient (−1.5), provider (2.5), or patient-provider (−0.7) intervention groups. At 12 months, all groups had improvements in WOMAC scores (−3.7 to −7.7). Compared with usual care, there were no differences in objective physical function or depressive symptoms in any of the intervention groups at 12 months.

"Contrary to a previous study of a combined patient and provider intervention for osteoarthritis in a Department of Veterans Affairs medical center, this study found no statistically significant improvements in the osteoarthritis intervention groups compared with usual care," the authors write.

One author disclosed financial ties to the pharmaceutical industry; one author disclosed financial ties to Weight Watchers International.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

FDA Approves First Generic Under-the-Tongue Suboxone

FDA Approves First Generic Under-the-Tongue Suboxone

May only be prescribed by Drug Addiction Treatment Act-certified prescribers

Kellogg's Honey Smacks Cereal Recalled Due to Salmonella Risk

Kellogg's Honey Smacks Cereal Recalled Due to <i>Salmonella</i> ...

Twenty-four people have been hospitalized, but no deaths have been reported

Portable Music Player Use Linked to Hearing Loss in Children

Portable Music Player Use Linked to Hearing Loss ...

Increased odds of high-frequency hearing loss with portable music player use

is free, fast, and customized just for you!




Already a member?

Sign In Now »